Hesse B, Tägil K, Cuocolo A, Anagnostopoulos C, Bardiés M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie P Y, McKiddie F, O'Connor M, Prvulovich E, Underwood R, van Eck-Smit B
Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):855-97. doi: 10.1007/s00259-005-1779-y.
The European procedural guidelines for radionuclide imaging of myocardial perfusion and viability are presented in 13 sections covering patient information, radiopharmaceuticals, injected activities and dosimetry, stress tests, imaging protocols and acquisition, quality control and reconstruction methods, gated studies and attenuation-scatter compensation, data analysis, reports and image display, and positron emission tomography. If the specific recommendations given could not be based on evidence from original, scientific studies, we tried to express this state-of-art. The guidelines are designed to assist in the practice of performing, interpreting and reporting myocardial perfusion SPET. The guidelines do not discuss clinical indications, benefits or drawbacks of radionuclide myocardial imaging compared to non-nuclear techniques, nor do they cover cost benefit or cost effectiveness.
欧洲心肌灌注和存活心肌放射性核素成像程序指南分为13个部分，涵盖患者信息、放射性药物、注射活度和剂量学、负荷试验、成像方案与采集、质量控制与重建方法、门控研究与衰减-散射校正、数据分析、报告与图像显示以及正电子发射断层扫描。如果所给出的具体建议并非基于原始科学研究的证据，我们会尽力呈现当前的技术水平。这些指南旨在协助进行、解读和报告心肌灌注单光子发射计算机断层显像（SPET）。指南未讨论放射性核素心肌成像与非核技术相比的临床适应证、益处或缺点，也未涉及成本效益或成本效果。
